Increased cerebrovascular pCO2 reactivity in migraine with aura- a transcranial Doppler study during hyperventilation, Cephalalgia, vol.15, issue.3, pp.211-216, 1995. ,
DOI : 10.1046/j.1468-2982.1995.015003211.x
Mécanismes des céphalées, pp.25-44 ,
La migraine, une céphalée primitive particulière. Actualités Pharmaceutiques, Janv, vol.50, issue.502, pp.12-19, 2011. ,
Explorations dans la migraine In: La migraine. Connaissances descriptives, traitements et prévention, Paris: INSERM, pp.141-61, 1998. ,
Le syndrome d'hyperventilation pulmonaire chez l'enfant, revue de la littérature. Revue Française d'Allergologie et d'Immunologie Clinique, Janv, vol.47, issue.1, pp.16-21, 2007. ,
Cerebrovascular reactivity to hypercapnia in migraine patients measured with near-infrared spectroscopy, Brain Research, vol.1107, issue.1, 2006. ,
DOI : 10.1016/j.brainres.2006.06.002
Hyperventilation et agression c??r??brale??: les risques de l'hypocapnie, Annales Fran??aises d'Anesth??sie et de R??animation, vol.26, issue.4 ,
DOI : 10.1016/j.annfar.2007.02.013
Controlled transient hypercapnia: a novel approach for the treatment of delayed cerebral ischemia after subarachnoid hemorrhage?, Journal of Neurosurgery, vol.121, issue.5, 2014. ,
DOI : 10.3171/2014.7.JNS132611
Cerebrovascular CO2 reactivity in migraine: assessment by transcranial Doppler ultrasound, Journal of Neurology, vol.236, issue.1, pp.23-26, 1991. ,
DOI : 10.1007/BF00319705
Rating of Perceived Exertion and Acute Mountain Sickness During a High-Altitude Trek, Aviation, Space, and Environmental Medicine, vol.85, issue.12, pp.1214-1220, 2014. ,
DOI : 10.3357/ASEM.4083.2014
The incidence,importance, and prophylaxis of acute mountain sickness. The Lancet, pp.1149-55, 1976. ,
Prevalence of and risk factors for acute mountain sickness among a cohort of highaltitude travellers who received pre-travel counselling, Travel Med Infect Dis, 2014. ,
Cerebral Blood Flow at High Altitude, High Altitude Medicine & Biology, vol.15, issue.2, pp.133-173 ,
DOI : 10.1089/ham.2013.1138
Physiological Risk Factors for Severe High-Altitude Illness, American Journal of Respiratory and Critical Care Medicine, vol.185, issue.2, 2012. ,
DOI : 10.1164/rccm.201108-1396OC
Epidemiology and comorbidity of headache. The Lancet Neurology, pp.354-61, 2008. ,
Prevalence and clinical characteristics of migraine in France, Neurology, vol.59, issue.2, pp.232-239, 2002. ,
DOI : 10.1212/WNL.59.2.232
Framig 99, Lettre Neurol, vol.4, pp.5-19, 2000. ,
Migraine and Probable Migraine ??? Results of FRAMIG 3, a French Nationwide Survey Carried out According to the 2004 IHS Classification, Cephalalgia, vol.23, issue.12, pp.1146-58, 2005. ,
DOI : 10.1111/j.1600-0447.1983.tb09716.x
Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies, Developmental Medicine & Child Neurology, vol.22, issue.Suppl. 5 ,
DOI : 10.1111/j.1469-8749.2010.03793.x
Migraine and headache in childhood]. Arch Pediatr, 2005. ,
Prise en charge diagnostique et thérapeutique de la migraine chez l'adulte et chez l'enfant. Douleurs : Evaluation -Diagnostic ? Traitement, pp.165-180, 2013. ,
Prise en charge de la migraine en m??decine g??n??rale, Revue Neurologique, vol.161, issue.10, pp.949-56, 2005. ,
DOI : 10.1016/S0035-3787(05)85158-6
TO02 -Framig III : Enquête auprès de l'entourage du migraineux. Résultats. Douleurs : Evaluation -Diagnostic -Traitement ,
A nosographic analysis of the migraine aura in a general population, Brain, vol.119, issue.2, pp.355-61, 1996. ,
DOI : 10.1093/brain/119.2.355
Migraine ophtalmique ou migraine avec aura visuelle, EMC - Ophtalmologie, vol.1, issue.1, p.7, 2001. ,
DOI : 10.1016/S0246-0343(01)00055-7
Migraine et c??phal??e de tension??: ce que doit conna??tre le rhumatologue, Revue du Rhumatisme Monographies, vol.80, issue.1 ,
DOI : 10.1016/j.monrhu.2012.08.001
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, vol.55, issue.6, pp.754-62, 2000. ,
DOI : 10.1212/WNL.55.6.754
Migraine de l'adulte??: diagnostic, ??valuation et traitement, EMC - Trait?? de m??decine AKOS, vol.6, issue.2, pp.5-1131, 2001. ,
DOI : 10.1016/S1634-6939(11)52322-1
French guidelines for the diagnosis and management of migraine in adults and children, Clinical Therapeutics, vol.26, issue.8, 2004. ,
DOI : 10.1016/S0149-2918(04)80161-9
URL : https://hal.archives-ouvertes.fr/inserm-00939010
me too : cinquième triptan pour les crises migraineuses sans progrès, Revue Prescrire, vol.23, issue.245, p.815, 2003. ,
Médicaments de la migraine, 21ème forum de Rangueil, 2009. ,
Efficacy of biofeedback for migraine: A meta-analysis, Pain, vol.128, issue.1, pp.111-138, 2007. ,
DOI : 10.1016/j.pain.2006.09.007
FRAMIG 2000: Medical and Therapeutic Management of Migraine in France, Cephalalgia, vol.21, issue.4, pp.267-79, 2005. ,
DOI : 10.1016/s0304-3959(02)00348-2
La migraine en pharmacie d'officine : une étude multi-centrique française. Revue Neurologique, Avr, vol.160, issue.4 1, pp.441-447, 2004. ,
??valuation de la qualit?? de vie en ??ducation th??rapeutique du patient diab??tique??: int??r??ts et limites des ??chelles de mesure standardis??es, Médecine des Maladies Métaboliques, pp.291-294, 2008. ,
DOI : 10.1016/S1957-2557(08)71675-4
Psychological, Sleep, Lifestyle, and Comorbid Associations With Headache, Headache: The Journal of Head and Face Pain, vol.116, issue.6, pp.657-69, 2005. ,
DOI : 10.1001/archinte.163.9.1058
Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults, Journal of Clinical Epidemiology, vol.48, issue.8, pp.1051-60, 1995. ,
DOI : 10.1016/0895-4356(94)00227-H
Quality of life and migraine. Validation of the QVM questionnaire in hospital consultation and in general medicine], Therapie, vol.48, issue.2, pp.89-96, 1993. ,
Medication-overuse headache: epidemiology, diagnosis and treatment, Therapeutic Advances in Drug Safety, vol.61, issue.2, pp.87-99 ,
DOI : 10.1212/01.WNL.0000123262.96132.FC
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110872
C??phal??es de tension, migraines : les bonnes questions, l???abord diagnostique et th??rapeutique, Archives de P??diatrie, vol.18, issue.5, pp.197-205, 2011. ,
DOI : 10.1016/S0929-693X(11)71035-1
Comparative efficacy trial of cupping and serkangabin versus conventional therapy of migraine headaches: A randomized, open-label, comparative efficacy trial, J Res Med Sci, vol.19, issue.12, pp.1134-1143, 2014. ,
Efficacy and Tolerability of STOPAIN for a Migraine Attack, Front Neurol, vol.6, p.11, 2015. ,
Effects of pregabalin on central sensitization in patients with migraine, Int. Journal of Clinical Pharmacology and Therapeutics, 2015. ,
DOI : 10.5414/CP202205
Cinnarizine versus Topiramate in Prophylaxis of Migraines among Children and Adolescents: A Randomized, Double-Blind Clinical Trial, Iran J Child Neurol, vol.8, issue.4, pp.18-27, 2014. ,
Therapeutic effect of intranasal evaporative cooling in patients with migraine: a pilot study, The Journal of Headache and Pain, vol.16, issue.1, p.5, 2015. ,
DOI : 10.1146/annurev-cellbio-101011-155833
Evidence-based guidelines in the primary care setting. Behavioral and physical treatments, 2000. ,